Article Menu

Export Article

More by Authors Links

Article Data

  • Views 1097
  • Dowloads 145

Case Reports

Open Access

Hypersensitivity reaction to carboplatin: successful resolution by replacement with cisplatin

  • G. Porzio1,*,
  • P. Marchetti1
  • I. Paris1
  • F. Narducci1
  • E. Ricevuto1
  • C. Ficorella1

1Medical Oncology Unit, University of L'Aquila, Italy

DOI: 10.12892/ejgo200204335 Vol.23,Issue 4,July 2002 pp.335-336

Published: 10 July 2002

*Corresponding Author(s): G. Porzio E-mail:

PDF (207.31 kB) View Full-text

Abstract

Hypersensitivity reactions caused by carboplatin rarely occur. These reactions can cause lethal complications and make subsequent therapeutic approaches difficult. To date, only a few cases of successful resolution of hypersensitivity by replacement of carboplatin with cisplatin have been reported. We report on a patient with serous papillary extra-ovarian peritoneal carcinoma who developed a hypersensitivity reaction after the 10th weekly administration of carboplatin. Two weeks after reaction, intradermal skin testing with paclitaxel, carboplatin, cisplatin, and mannitol showed intense reaction only to carboplatin. On the basis of these results, the patient was changed to a chemotherapy with cisplatin and paclitaxel. A further eight courses of chemotherapy were administered without evidence of hypersensitivity reactions. Carboplatin seems to be successfully replaceable by cisplatin in case of hypersensitivity reactions.


Keywords

Carboplatin; Hypersensitivity; Cisplatin replacement

Cite and Share

G. Porzio,P. Marchetti,I. Paris,F. Narducci,E. Ricevuto,C. Ficorella. Hypersensitivity reaction to carboplatin: successful resolution by replacement with cisplatin. European Journal of Gynaecological Oncology. 2002. 23(4);335-336.

URL:

https://www.ejgo.net/articles/10.12892/ejgo200204335

References

[I] Shukunami K., Kurokawa T., Kawakami Y., Kubo M., Kotsuji F.: "Hypersensitivity reactions to intraperitoneal administration of carboplatin to ovarian cancer: the first report of a case". Gynecol Oneal., 1999, 72, 431.

[2] Rose P. G., Fusco N., Fluellen L. et al.: "Carboplatin hypersensitivity rea(,tions in patients with ovarian and peritoneal carcinoma" Int. J. Gynecol. Cancer, 1998, R, 365.

[3] Markman M., Kennedy A., Webster K. et al.: "Clinical features of hypersensitivity reactions to carboplatin". J. Clin. Oncol., 1999, 17, 1141.

[4] Hendrick A. M., Simmons D., Cantwell B. M.J.: "Allergic reaction to carboplatin". Ann. Oncol., 1992, 3, 239.

[5] Wiedmann B., Mulleneisen N., Bojko P;, Neiderle N.: "Hypersensitivity reactions to carboplatin". Cancer, 1994, 73, 2218.

[6] Shukunami K., Kurosawa T., Kubo M., Kaneshima M., Kamitani N., Kotsuji F: "Hypersensitivity reaction to carboplati? during treatment for ovarian cancer: successful resolution by replacement with cisplatin". Tumori, 1999, 85, 297.

[7] Broome C. B., Schiff R. I., Friedman H. S.:''Successful desensitization to carboplatin in patients with systemic hypersensitivity reactions". Med. Pediatr. Oncol., 1996, 26, 105.

[8] Kook H., Kim R. M., Choi S. H. et al.: "Life-treatening carboplatin hypersensitivity during conditioning for autologous PBSC transplantation: Successful rechallenge after desensitization". Bone Marrow Transplant, 1998, 21, 727,

[9] Zanotti K. M., Rybicki LA., Kennedy A. W. et al.: "Carboplatm skin testing: a skin-testing protocol for predicting hipersensitivity to carboplatin chemotherapy". J. Clin. Oneal., 2001, 19, 3126.

[10] Shelback A. A., Clark P. I., Green J. A.: "Hypersensitivity and cross-reactivity to cisplatin and analogues". Cancer Chemother. Pharmacol., 1995, 35, 349.

Submission Turnaround Time

Top